Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) study

PharmacoEconomics

Volumn 20, Issue 2, 2002, Pages 91-100

  Sculpher, M ^a   Millson, D ^b   Meddis, D ^c   Poole, L ^c  

^a UNIVERSITY OF YORK   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; METOCLOPRAMIDE; ZOLMITRIPTAN;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISABILITY; DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG SPECIFICITY; DRUG UTILIZATION; HEADACHE; HUMAN; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MIGRAINE; PRIORITY JOURNAL; PRODUCTIVITY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0036209497     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200220020-00002     Document Type: Article

References (31)

1. A practical guide to the management and prevention of migraine
2. Guidelines for the diagnosis and management of migraine in clinical practice
3. Disability assessment as a basis for stratified care
4. Clinical applications of zolmitriptan (Zomig, 311C90)
5. Stratified care vs step care strategies for migraine: The Disability in Strategies of Care (DISC) study: A randomised trial
6. The cost effectiveness of stratified care in the management of migraine
7. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score
8. Reliability of the Migraine Disability Assessment Score in a population-based sample of headache sufferers
9. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers
10. Productivity costs in cost-effectiveness analysis: Numerator or denominator: A further discussion
11. The friction cost method of measuring the indirect costs of disease
12. On the decision rules of cost-effectiveness analysis
13. Costs, effects and c/e-ratios alongside a clinical trial
14. Representing uncertainty: The role of cost-effectiveness acceptability curves
15. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS40
16. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: A randomised controlled trial in primary care
17. Handling uncertainty when performing economic evaluation of healthcare interventions
18. A Bayesian approach to stochastic cost-effectiveness analysis
19. The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies
20. Cost-utility analysis from a societal perspective